Hyperlipoproteinemia Type V: Clinical Trials

2 trials for Hyperlipoproteinemia Type V, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 1, Unknown 1

Follow Hyperlipoproteinemia Type V: new trials by email Literature Review of Hyperlipoproteinemia Type V trials Research Report on Hyperlipoproteinemia Type V

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
CTX310 - Cardiovascular, Metabolic Disease
Phase 1RecruitingCRISPR Therapeutics AG902024-06-212026-09-18
Study to Evaluate the Safety and PK of UI018
administration of UI018, co-administration of UIC201806 and UIC201602 - Hyperlipemia, Mixed
Phase 1UnknownKorea United Pharm. Inc.442021-09-062021-12-21

Narrower conditions

Dyslipidemias (1)  ·  Homozygous Familial Hypercholesterolemia (1)  ·  Hypercholesterolemia (1)  ·  Hypertriglyceridemia (1)  ·  Lipid Metabolism Disorders (1)  ·  Metabolic Diseases (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Hyperlipidemias (2)  ·  Hyperlipoproteinemias (2)  ·  Lipid Metabolism, Inborn Errors (2)  ·  Metabolism, Inborn Errors (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Dyslipidemias (1)  ·  Hyperlipoproteinemia Type II (1)  ·  Hypertriglyceridemia (1)  ·  Lipid Metabolism Disorders (1)  ·  Metabolic Diseases (1)

Sponsors

CRISPR Therapeutics AG (1)  ·  Korea United Pharm. Inc. (1)

Countries

Australia (1)  ·  New Zealand (1)  ·  South Korea (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Injin Jang, Dr. (1)